Artyx Pharmaceuticals, Inc.

San Diego, CA 92123

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $397K
First Award Date 05/01/06
Most Recent Award Date 05/01/08

Key Personnel

Last Name Name Awards Contact
Lotz Martin K. Lotz 3

3 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/08 - 04/30/09

DESCRIPTION (provided by applicant): Osteoarthritis (OA) is the most prevalent joint disease, causing joint pain and dysfunction. OA is also associated with substantial co-morbidity and reduces life expectancy. Pharmacologic therapy is limited to symptom modification and disease-modifying therapies are currently not available. Furthermore, even ...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/07 - 04/30/08

DESCRIPTION (provided by applicant): Osteoarthritis (OA) is the most prevalent joint disease, causing joint pain and dysfunction. OA is also associated with substantial co-morbidity and reduces life expectancy. Pharmacologic therapy is limited to symptom modification and disease-modifying therapies are currently not available. Furthermore, even ...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/06 - 04/30/07

DESCRIPTION (provided by applicant): Osteoarthritis (OA) is the most prevalent joint disease, causing joint pain and dysfunction. OA is also associated with substantial co-morbidity and reduces life expectancy. Pharmacologic therapy is limited to symptom modification and disease-modifying therapies are currently not available. Furthermore, even ...